Application Nr Approved Date Route Status External Links
NDA020613 1996-09-06 Ophthalmic DISCN Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Brimonidine Tartrate Ophthalmic Solution Is Indicated For Lowering Intraocular Pressure In Patients With Open-Angle Glaucoma Or Ocular Hypertension. The Iop Lowering Efficacy Of Brimonidine Tartrate Ophthalmic Solution Diminishes Over Time In Some Patients. This Loss Of Effect Appears With A Variable Time Of Onset In Each Patient And Should Be Closely Monitored.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Brimonidine Tartrate BRIMONIDINE TARTRATE ZINC895301

Comments